SG11201401851UA - Methods for drug delivery - Google Patents

Methods for drug delivery

Info

Publication number
SG11201401851UA
SG11201401851UA SG11201401851UA SG11201401851UA SG11201401851UA SG 11201401851U A SG11201401851U A SG 11201401851UA SG 11201401851U A SG11201401851U A SG 11201401851UA SG 11201401851U A SG11201401851U A SG 11201401851UA SG 11201401851U A SG11201401851U A SG 11201401851UA
Authority
SG
Singapore
Prior art keywords
methods
drug delivery
drug
delivery
Prior art date
Application number
SG11201401851UA
Inventor
Jason Frazier
Richard Klinghoffer
Marc Grenley
Original Assignee
Presage Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Presage Biosciences Inc filed Critical Presage Biosciences Inc
Publication of SG11201401851UA publication Critical patent/SG11201401851UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/42Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
    • A61M5/427Locating point where body is to be pierced, e.g. vein location means using ultrasonic waves, injection site templates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
SG11201401851UA 2011-10-28 2012-10-26 Methods for drug delivery SG11201401851UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161553003P 2011-10-28 2011-10-28
US201261680847P 2012-08-08 2012-08-08
PCT/US2012/062313 WO2013063530A2 (en) 2011-10-28 2012-10-26 Methods for drug delivery

Publications (1)

Publication Number Publication Date
SG11201401851UA true SG11201401851UA (en) 2014-05-29

Family

ID=48168805

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201508662SA SG10201508662SA (en) 2011-10-28 2012-10-26 Methods for drug delivery
SG11201401851UA SG11201401851UA (en) 2011-10-28 2012-10-26 Methods for drug delivery

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201508662SA SG10201508662SA (en) 2011-10-28 2012-10-26 Methods for drug delivery

Country Status (8)

Country Link
US (3) US20140323907A1 (en)
EP (1) EP2771043A4 (en)
JP (1) JP2014534864A (en)
CN (1) CN104023760A (en)
AU (1) AU2012328457A1 (en)
CA (1) CA2851828A1 (en)
SG (2) SG10201508662SA (en)
WO (1) WO2013063530A2 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2600901B1 (en) 2010-08-06 2019-03-27 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
HRP20220796T1 (en) 2010-10-01 2022-10-14 ModernaTX, Inc. Ribonucleic acids containing n1-methyl-pseudouracils and uses thereof
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3492109B1 (en) 2011-10-03 2020-03-04 ModernaTX, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
EP2771043A4 (en) 2011-10-28 2015-04-29 Presage Biosciences Inc Methods for drug delivery
RS63244B1 (en) 2011-12-16 2022-06-30 Modernatx Inc Modified mrna compositions
WO2013151664A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9199044B2 (en) * 2012-08-06 2015-12-01 Elwha Llc Devices and methods for wearable injection guides
PL2922554T3 (en) 2012-11-26 2022-06-20 Modernatx, Inc. Terminally modified rna
EP2974768A4 (en) * 2013-03-12 2017-05-17 Takeda Pharmaceutical Company Limited Micro-needle patch
WO2014152211A1 (en) 2013-03-14 2014-09-25 Moderna Therapeutics, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
CA2923029A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
EP3052106A4 (en) 2013-09-30 2017-07-19 ModernaTX, Inc. Polynucleotides encoding immune modulating polypeptides
SG11201602503TA (en) 2013-10-03 2016-04-28 Moderna Therapeutics Inc Polynucleotides encoding low density lipoprotein receptor
US20170049503A1 (en) * 2014-05-15 2017-02-23 Cosman Medical, Inc. Electrosurgical system
EP3169693B1 (en) 2014-07-16 2022-03-09 ModernaTX, Inc. Chimeric polynucleotides
US20170210788A1 (en) 2014-07-23 2017-07-27 Modernatx, Inc. Modified polynucleotides for the production of intrabodies
US20160178519A1 (en) * 2014-12-23 2016-06-23 Boston Scientific Scimed, Inc. Marker For Detection And Confirmation Of Peripheral Lung Nodules
CN105012042B (en) * 2015-06-05 2017-02-01 中国农业科学院兰州兽医研究所 Immune apparatus for intracutaneous inoculation used for living vaccines
EP4349405A3 (en) 2015-10-22 2024-06-19 ModernaTX, Inc. Respiratory virus vaccines
CN108136216B (en) * 2015-10-23 2021-08-24 诺华股份有限公司 Method of scoring a sample comprising tumor tissue
RS63135B1 (en) 2015-12-23 2022-05-31 Modernatx Inc Methods of using ox40 ligand encoding polynucleotides
US20190241658A1 (en) 2016-01-10 2019-08-08 Modernatx, Inc. Therapeutic mRNAs encoding anti CTLA-4 antibodies
GB201600445D0 (en) * 2016-01-11 2016-02-24 Cairns Intellectual Property Ltd Methods and apparatuses for temperature measurement
EP3419542A4 (en) * 2016-02-25 2019-11-06 The General Hospital Corporation Method and apparatus for tightening skin and other tissues
WO2018028780A1 (en) * 2016-08-10 2018-02-15 Saga Surgical Ab A biopsy needle arrangement
WO2018132430A1 (en) 2017-01-10 2018-07-19 A.T. Still Universiy Fluid infusion system
CN107617140B (en) * 2017-08-15 2022-06-24 杭州德柯医疗科技有限公司 Ventricular wall injection auxiliary instrument
WO2019164842A1 (en) * 2018-02-20 2019-08-29 Boston Scientific Scimed, Inc. Systems for regulating glucose levels including treating diabetes
IL277195B2 (en) * 2018-03-13 2024-04-01 Vertex Pharma Implantation devices, system, and methods
CN114391040A (en) 2019-09-23 2022-04-22 欧米茄治疗公司 Compositions and methods for modulating apolipoprotein B (APOB) gene expression
US11987791B2 (en) 2019-09-23 2024-05-21 Omega Therapeutics, Inc. Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression
CN110522969B (en) * 2019-09-25 2021-08-27 合肥京东方光电科技有限公司 Injection device, infusion equipment and injection control method
CN111134894B (en) * 2020-01-17 2022-02-22 上海长海医院 Sampling method for in vivo determination of continuous dynamic free drug concentration of canine prostate tissue
CN116096886A (en) 2020-03-11 2023-05-09 欧米茄治疗公司 Compositions and methods for modulating fork-box P3 (FOXP 3) gene expression
EP4367242A2 (en) 2021-07-07 2024-05-15 Omega Therapeutics, Inc. Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
WO2023154908A2 (en) * 2022-02-11 2023-08-17 Board Of Regents, The University Of Texas System Convection-enhanced thermo-chemotherapy catheter system
WO2023161350A1 (en) 2022-02-24 2023-08-31 Io Biotech Aps Nucleotide delivery of cancer therapy
CN219700059U (en) * 2022-06-10 2023-09-19 湖州大士医疗科技有限公司 Clamping rod type multichannel clamping mechanism
GB202216449D0 (en) 2022-11-04 2022-12-21 Io Biotech Aps TGF-BETA1 vaccine

Family Cites Families (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4164559A (en) 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
US4256153A (en) 1979-07-09 1981-03-17 Societe Francaise Pour Le Developpement De L'automatisme En Biologie Device for simultaneous transfer of a plurality of liquids
US4966159A (en) 1981-12-14 1990-10-30 Maganias Nicholas H Allergy test strip
US4673565A (en) 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
US5335670A (en) 1986-04-18 1994-08-09 Henry Fishman Allergy testing method and apparatus
US5154181A (en) 1986-04-18 1992-10-13 Henry Fishman Allergy testing method and apparatus
BR8707670A (en) 1986-04-18 1989-08-15 Henry Fishman ALLERGY TESTING APPLIANCE AND PROCESS
US5605160A (en) 1986-04-18 1997-02-25 Fishman; Henry Allergy testing apparatus with variably spaced test testing sites
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4865582A (en) 1987-06-05 1989-09-12 Drug Delivery Systems Inc. Disposable transdermal drug applicators
JPS63315064A (en) 1987-06-18 1988-12-22 Kazuki Tsutsumi Injection needle
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
JPH01122758U (en) 1988-02-17 1989-08-21
US4936835A (en) * 1988-05-26 1990-06-26 Haaga John R Medical needle with bioabsorbable tip
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5104620A (en) 1990-07-30 1992-04-14 Wiley Fred R Disposable allergy skin testing kit
CA2090860C (en) 1990-11-21 2003-09-16 Richard A. Houghten Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
US5885769A (en) 1991-02-14 1999-03-23 Schering Corporation Screening systems
US5474909A (en) * 1992-08-07 1995-12-12 Anticancer, Inc. Noncolorimetric histoculture method for predicting drug response of tumors
US5565324A (en) 1992-10-01 1996-10-15 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
IL107038A (en) 1992-10-05 1997-04-15 Senetek Plc Medicament injectors and methods for injection using same
US5993434A (en) 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
US5536267A (en) 1993-11-08 1996-07-16 Zomed International Multiple electrode ablation apparatus
AU7552394A (en) 1993-12-15 1995-07-03 Combichem, Inc. Combinatorial libraries and methods for their use
US5457041A (en) 1994-03-25 1995-10-10 Science Applications International Corporation Needle array and method of introducing biological substances into living cells using the needle array
US8795242B2 (en) 1994-05-13 2014-08-05 Kensey Nash Corporation Resorbable polymeric device for localized drug delivery
US5876380A (en) 1994-10-19 1999-03-02 Manganini; Steven J. Portable syringe dispenser system
US5693341A (en) 1995-03-16 1997-12-02 Collagen Corporation Affinity bound collagen matrices for the delivery of biologically active agents
US5751629A (en) 1995-04-25 1998-05-12 Irori Remotely programmable matrices with memories
US5538134A (en) 1995-07-25 1996-07-23 Pitesky; Isadore Disposable allergen container and pick apparatus
ATE272058T1 (en) 1995-10-17 2004-08-15 Combichem Inc MATRIZE FOR SYNTHESIS OF COMBINATORIAL LIBRARIES IN SOLUTION
SE9503685D0 (en) 1995-10-20 1995-10-20 Pharmacia Ab Arrangement in electronically controlled injection devices
AUPN880396A0 (en) 1996-03-21 1996-04-18 Fremantle Hospital Animal model for transplantation
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US20040072722A1 (en) 2002-10-10 2004-04-15 Kornblith Paul L. Methods for assessing efficacy of chemotherapeutic agents
US5798035A (en) 1996-10-03 1998-08-25 Pharmacopeia, Inc. High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay
US5832878A (en) 1997-01-10 1998-11-10 Emory University Apparatus permitting tethered laboratory animals to move freely
AU5907598A (en) * 1997-01-10 1998-08-03 Emory University Sample collection and drug delivery apparatus for freely-moving tethered laboratory animals
US5865766A (en) * 1997-01-10 1999-02-02 Emory University Multichannel, multipurpose sample collection and drug delivery system for laboratory animals
US5846225A (en) 1997-02-19 1998-12-08 Cornell Research Foundation, Inc. Gene transfer therapy delivery device and method
US6953662B2 (en) 1997-08-29 2005-10-11 Human Genome Sciences, Inc. Follistatin-3
US20040033230A1 (en) 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20060015058A1 (en) 1998-01-08 2006-01-19 Kellogg Scott C Agents and methods for enhancement of transdermal transport
US6286455B1 (en) 1998-01-12 2001-09-11 Embrex, Inc. Automated in ovo injection apparatus
US6208893B1 (en) 1998-01-27 2001-03-27 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6146594A (en) 1999-02-10 2000-11-14 Robbins Scientific Corporation Syringe array with adjustable needle spacing
US6972013B1 (en) 1998-07-13 2005-12-06 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
GB9815819D0 (en) 1998-07-22 1998-09-16 Secr Defence Transferring materials into cells and a microneedle array
DE69920489T2 (en) 1998-07-29 2005-12-01 Texaco Development Corp. INTEGRATED SOLVENT TASTE PACKAGING AND GASIFICATION PROCESS
IL141148A0 (en) 1998-07-30 2002-02-10 Solexa Ltd Arrayed biomolecules and their use in sequencing
US6358276B1 (en) 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6330479B1 (en) 1998-12-07 2001-12-11 The Regents Of The University Of California Microwave garment for heating and/or monitoring tissue
DE60021330T2 (en) 1999-01-06 2006-04-20 United States Surgical Corp., Norwalk INJECTION DEVICE FOR CONTRASTING AGENTS FOR TISSUE PRESENTATION
US6685913B1 (en) 1999-03-09 2004-02-03 Thomas Jefferson University Lipid soluble radioactive metal chelates for tumor therapy
AU778736B2 (en) 1999-03-25 2004-12-16 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response
CA2368611A1 (en) 1999-03-25 2000-09-28 Nicholas F. D'antonio Hypodermic injection system
US6689103B1 (en) 1999-05-07 2004-02-10 Scimed Life System, Inc. Injection array apparatus and method
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US7030097B1 (en) 1999-07-14 2006-04-18 Cornell Research Foundation, Inc. Controlled nucleic acid delivery systems
US7141234B1 (en) * 1999-09-21 2006-11-28 The United States Of America As Represented By The Department Of Health And Human Services Imaging of drug accumulation as a guide to antitumor therapy
US20010053891A1 (en) * 1999-12-30 2001-12-20 Ackley Donald E. Stacked microneedle systems
US6558361B1 (en) 2000-03-09 2003-05-06 Nanopass Ltd. Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
US6428504B1 (en) 2000-04-06 2002-08-06 Varian Medical Systems, Inc. Multipurpose template and needles for the delivery and monitoring of multiple minimally invasive therapies
US6468247B1 (en) 2000-04-21 2002-10-22 Mark Zamoyski Perfusion device for localized drug delivery
US6620403B2 (en) 2000-04-26 2003-09-16 Roman Perez-Soler In vivo chemosensitivity screen for human tumors
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6482187B1 (en) 2000-10-23 2002-11-19 Fred O. Gibbs Animal identification and medication syringe
US6616626B2 (en) 2000-12-21 2003-09-09 Scimed Life Systems, Inc. Infusion devices and method
GB0100247D0 (en) 2001-01-05 2001-02-14 Univ Dundee Improved hypodermic needle and fluid injection device
US7850663B2 (en) 2001-01-12 2010-12-14 Becton, Dickinson And Company Medicament microdevice delivery system, cartridge and method of use
DE60212799T2 (en) 2001-01-18 2006-11-09 Medrad, Inc. SPRAY CONNECTORS AND ADAPTERS FOR USE WITH MEDICAL INJECTORS
US7008421B2 (en) * 2002-08-21 2006-03-07 Resect Medical, Inc. Apparatus and method for tissue resection
US7563255B2 (en) * 2001-05-03 2009-07-21 Massachusetts Eye And Ear Infirmary Implantable drug delivery device and use thereof
WO2003000129A2 (en) 2001-06-22 2003-01-03 University Of Florida Microdialysis probes and methods of use
US6796957B2 (en) 2001-07-10 2004-09-28 Myocardial Therapeutics, Inc. Sterile aspiration/reinjection systems
DE60233574D1 (en) 2001-07-10 2009-10-15 Univ R METHOD AND COMPOSITIONS FOR DETECTING THE ACTIVATION CONDITION OF MULTIPLE PROTEINS IN INDIVIDUAL CELLS
US20030060780A1 (en) 2001-09-24 2003-03-27 Shu Hang Chung Epidermic injection device
US20030134810A1 (en) 2001-10-09 2003-07-17 Chris Springate Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
US7429258B2 (en) 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US6840921B1 (en) 2002-01-11 2005-01-11 Timothy D. Haider Apparatus and methods for simultaneously administering two or more medications to a patient
US20050154434A1 (en) 2002-03-07 2005-07-14 Adam Simon Clinical syringe with electrical stimulation aspects
US6942633B2 (en) * 2002-03-22 2005-09-13 Twin Star Medical, Inc. System for treating tissue swelling
JP4044779B2 (en) 2002-04-02 2008-02-06 株式会社根本杏林堂 Chemical injection system
US6780171B2 (en) 2002-04-02 2004-08-24 Becton, Dickinson And Company Intradermal delivery device
EP1539282A2 (en) 2002-08-06 2005-06-15 GenVec, Inc. Improved injection system
US20050187303A1 (en) 2002-09-26 2005-08-25 Wu Men-Dar Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
US20060206950A1 (en) 2002-11-04 2006-09-14 Kaelin William G Jr In vivo imaging of e2f-fegulated bioluminescent proteins
US6896666B2 (en) 2002-11-08 2005-05-24 Kochamba Family Trust Cutaneous injection delivery under suction
EP1638523B8 (en) 2003-06-30 2013-12-25 ALZA Corporation Formulations for coated microprojections containing non-volatile counterions
JP2007130028A (en) 2003-07-01 2007-05-31 Junko Asano Medication-coated medical device
US7358046B2 (en) 2003-08-08 2008-04-15 Canbas Co., Ltd. Sensitivity test to predict efficacy of anti-cancer therapies
IL157696A0 (en) 2003-09-01 2004-03-28 Hawk Medical Technologies Ltd Apparatus and method for removing a pigmented section of skin
JP4682144B2 (en) 2003-10-31 2011-05-11 アルザ・コーポレーシヨン Self-actuating applicator for microprojection arrays
US20050126304A1 (en) 2003-11-24 2005-06-16 Integrated Sensing Systems, Inc. Fluid infusion method and system therefor
US7674579B2 (en) * 2003-11-26 2010-03-09 Yale University Apoptosis-based evaluation of chemosensitivity in cancer patients
US20060094046A1 (en) 2004-02-11 2006-05-04 Arie Abo Compositions and methods relating to angiogenesis and tumorigenesis
WO2006015299A2 (en) 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
US20060058966A1 (en) 2004-09-15 2006-03-16 Bruckner Howard W Methods and systems for guiding selection of chemotherapeutic agents
US20060079846A1 (en) 2004-10-08 2006-04-13 Alton Williams Hypodermic syringes with multiple needles and methods of calming psychiatric patients using such
US7627938B2 (en) 2004-10-15 2009-12-08 Board Of Regents, The Univeristy Of Texas System Tapered hollow metallic microneedle array assembly and method of making and using the same
AU2005306426B2 (en) 2004-11-18 2011-04-28 3M Innovative Properties Company Masking method for coating a microneedle array
US8394410B2 (en) 2005-01-20 2013-03-12 Massachusetts Institute Of Technology Soft polylactides
JP2006239260A (en) 2005-03-07 2006-09-14 Hakko Co Ltd Medical solution syringe device
US20060224118A1 (en) 2005-03-31 2006-10-05 Morris Mary M Medical fluid delivery system
US20080009802A1 (en) 2005-04-25 2008-01-10 Danilo Lambino Method of treating acne with stratum corneum piercing device
DE602006019587D1 (en) 2005-04-27 2011-02-24 Bard Inc C R Syringe pumping system for injection of contrast agent in an intravenous line
US7850656B2 (en) 2005-04-29 2010-12-14 Warsaw Orthopedic, Inc. Devices and methods for delivering medical agents
US20080269666A1 (en) * 2005-05-25 2008-10-30 Georgia Tech Research Corporation Microneedles and Methods for Microinfusion
US20070093748A1 (en) 2005-06-23 2007-04-26 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
US7396524B2 (en) 2005-08-02 2008-07-08 Main Line Health Heart Center Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy
US20070038181A1 (en) * 2005-08-09 2007-02-15 Alexander Melamud Method, system and device for delivering a substance to tissue
US7967763B2 (en) 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
US7799035B2 (en) 2005-11-18 2010-09-21 Carefusion 2200, Inc. Device, system and method for delivering a curable material into bone
US8734823B2 (en) 2005-12-14 2014-05-27 The Invention Science Fund I, Llc Device including altered microorganisms, and methods and systems of use
US20070162110A1 (en) 2006-01-06 2007-07-12 Vipul Bhupendra Dave Bioabsorbable drug delivery devices
EP1986656A4 (en) * 2006-02-02 2012-05-16 Univ South Florida Withacnistin compounds for treatment of cancer
CA2642481C (en) 2006-02-16 2016-04-05 David W. Smith System utilizing radio frequency signals for tracking and improving navigation of slender instruments during insertion into the body
JP2009528131A (en) 2006-03-03 2009-08-06 ジェネトロニクス,インコーポレイティド Method and apparatus for treating microscopic residual tumor remaining in tissue after surgical resection
JPWO2007123274A1 (en) 2006-04-20 2009-09-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 Novel sensitivity markers for sulfonamide compounds
US20070287952A1 (en) * 2006-04-27 2007-12-13 Shah Jay P Microdialysis probe
US7771741B2 (en) 2006-05-01 2010-08-10 Warsaw Orthopedic, Inc Demineralized bone matrix devices
US7621895B2 (en) 2006-05-17 2009-11-24 Abbott Cardiovascular Systems Inc. Needle array devices and methods
EP2027256A2 (en) 2006-05-31 2009-02-25 Projech Science to Technology, S.L. Animal models of tumour metastasis and toxicity
US7922672B2 (en) 2006-06-08 2011-04-12 Lincoln Diagnostics, Inc. Skin testing-device system
BRPI0602640B8 (en) 2006-07-06 2021-05-25 Anhanguera Educacional Ltda methods of obtaining penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumor and antiparasitic properties, process for preparing 1,5-bis-(aryl)-penta-1,4-dien-3- alkylated and acylated ones, process for preparing substituted 4-nitro-3,5-diaryl-cyclohexanones, process for preparing 2,6-dibenzylidene-4-nitro-3,5-diaryl-substituted cyclohexanones, process for preparing a mixture formed from determined amounts of the compounds (1,5-bis(4-hydroxy-3-methoxy-phenyl)penta-1,4-dien-3-one) and (1,5-bis(3-methoxy-4-acetoxy-phenyl) ) penta-1,4-dien-3-one), compounds and their uses, pharmaceutical composition, therapeutic method for the treatment of cancers and synergistic composition
US20100100005A1 (en) * 2006-07-11 2010-04-22 Infotonics Technology Center, Inc. Minimally invasive allergy testing system with coated allergens
WO2008008845A2 (en) 2006-07-11 2008-01-17 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
WO2008023300A1 (en) 2006-08-21 2008-02-28 Koninklijke Philips Electronics N. V. Drug delivery device with piezoelectric actuator
DE102006040642A1 (en) 2006-08-30 2008-03-13 Robert Bosch Gmbh Microneedles for placement in the skin for transdermal application of pharmaceuticals
US7711409B2 (en) 2006-10-04 2010-05-04 Hampton University Opposed view and dual head detector apparatus for diagnosis and biopsy with image processing methods
US20080140026A1 (en) 2006-12-11 2008-06-12 Sliwa John W Acoustically-Aided and/or gel-aided delivery of beneficial gaseous, ionic, unstable, metastable, short-lived or reactive species for medical purposes
WO2008072229A2 (en) * 2006-12-12 2008-06-19 Nanopass Technologies Ltd. Methods for dermal filling using microneedles
US7935086B2 (en) 2006-12-14 2011-05-03 L M M Global Innovations, Inc. Multiple drug injection apparatus
WO2008079997A2 (en) 2006-12-22 2008-07-03 Medtronic, Inc. Implantable device, angiogenesis mechanism and methods
US20080214987A1 (en) 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US9114238B2 (en) * 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
WO2009009357A2 (en) 2007-07-06 2009-01-15 Boston Scientific Scimed, Inc. Implantable medical devices having adjustable pore volume and methods for making the same
SG183726A1 (en) 2007-08-14 2012-09-27 Hutchinson Fred Cancer Res Needle array assembly and method for delivering therapeutic agents
US20090093871A1 (en) 2007-10-08 2009-04-09 Medtronic Vascular, Inc. Medical Implant With Internal Drug Delivery System
US20090105562A1 (en) * 2007-10-19 2009-04-23 Taipei Veterans General Hospital System and methods for screening or analyzing targets
WO2009055542A1 (en) 2007-10-26 2009-04-30 University Of Utah Research Foundation Use of mri contrast agents for evaluating the treatment of tumors
US8233976B2 (en) 2007-12-05 2012-07-31 The Invention Science Fund I, Llc System for transdermal chemical modulation of neural activity
FR2924715B1 (en) 2007-12-06 2012-10-12 Arkema France MATERIAL FORMED ARBORESCENT MOLECULES COMPRISING ASSOCIATIVE GROUPS
US8398397B2 (en) 2008-03-12 2013-03-19 Ultradent Products, Inc. Dental intraligamentary injection needles and related methods of manufacture
WO2010022252A2 (en) 2008-08-21 2010-02-25 Third Rock Ventures Device and method for drug evaluation and local treatment
WO2010064251A1 (en) 2008-12-04 2010-06-10 Technion Research & Development Foundation Ltd Hydrogel sponges, methods of producing them and uses thereof
RU2011134043A (en) 2009-01-23 2013-02-20 Клт Инк. DELIVERY OF ONE OR MORE AGENT WITH LONG-TERM RELEASE
JP2013544600A (en) 2010-11-23 2013-12-19 プレサージュ バイオサイエンシズ,インコーポレイテッド Therapeutic methods and compositions for solid delivery
US20130280755A1 (en) 2010-11-23 2013-10-24 Fred Hutchinson Cancer Research Center Therapeutic methods for solid delivery
EP2771043A4 (en) 2011-10-28 2015-04-29 Presage Biosciences Inc Methods for drug delivery
EP2797582B1 (en) 2011-12-30 2019-03-13 Kibur Medical, Inc. Implantable devices and methods for the evaluation of active agent

Also Published As

Publication number Publication date
CA2851828A1 (en) 2013-05-02
WO2013063530A2 (en) 2013-05-02
US20140378944A1 (en) 2014-12-25
SG10201508662SA (en) 2015-11-27
EP2771043A2 (en) 2014-09-03
US20140323907A1 (en) 2014-10-30
CN104023760A (en) 2014-09-03
AU2012328457A1 (en) 2014-04-24
EP2771043A4 (en) 2015-04-29
US10478157B2 (en) 2019-11-19
US20170296154A1 (en) 2017-10-19
JP2014534864A (en) 2014-12-25
WO2013063530A3 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
SG11201401851UA (en) Methods for drug delivery
GB2512007B8 (en) Transdermal delivery system
IL232768A0 (en) Medicament delivery device
ZA201307378B (en) Medicament delivery device
EP2683328A4 (en) Delivery system
IL227712A0 (en) Medicament delivery device
EP2683431A4 (en) Medicant delivery system
GB201121069D0 (en) Delivery system
EP2708254A4 (en) Container for nasal administration
EP2793953A4 (en) Telodendrimers with enhanced drug delivery
HUE062316T2 (en) Drug delivery technology
LT2672973T (en) Administration regime for nitrocatechols
ZA201306604B (en) Drug delivery device
EP2788053A4 (en) Medicament delivery device
HRP20181316T1 (en) Drug delivery technology
PT3275507T (en) Vaccine delivery method
ZA201309156B (en) Drug delivery system
EP2756856A4 (en) Drug infusion system
GB201110632D0 (en) Drug delivery formulations
EP2667917A4 (en) Detachable drug delivery device
EP2687212A4 (en) Medicament
GB201121693D0 (en) Medicament delivery technology
GB201119796D0 (en) Pharmaceutical comopounds